相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Interaction with Ribosomal Proteins Accompanies Stress Induction of the Anticancer Metallodrug BOLD-100/KP1339 in the Endoplasmic Reticulum
Benjamin Neuditschko et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2021)
Metalloproteomics in conjunction with other omics for uncovering the mechanism of action of metallodrugs: Mechanism-driven new therapy development
Haibo Wang et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2020)
Plecstatin-1 induces an immunogenic cell death signature in colorectal tumour spheroids
Debora Wernitznig et al.
METALLOMICS (2020)
Introduction: Metals in Medicine
Katherine J. Franz et al.
CHEMICAL REVIEWS (2019)
Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapy
Jun Wang et al.
NATURE MEDICINE (2019)
Metalloproteomics for Unveiling the Mechanism of Action of Metallodrugs
Yuchuan Wang et al.
INORGANIC CHEMISTRY (2019)
Low-Dose Azacitidine, Pioglitazone and All-Trans Retinoic Acid Versus Standard-Dose Azacitidine in Patients ≥ 60 Years with Acute Myeloid Leukemia Refractory to Standard Induction Chemotherapy (AMLSG 26-16/AML-ViVA): Results of the Safety Run-in Phase I
Daniel Heudobler et al.
BLOOD (2019)
Gain Fat-Lose Metastasis: Converting Invasive Breast Cancer Cells into Adipocytes Inhibits Cancer Metastasis
Dana Ishay-Ronen et al.
CANCER CELL (2019)
Anakoinosis: Correcting Aberrant Homeostasis of Cancer Tissue-Going Beyond Apoptosis Induction
Daniel Heudobler et al.
FRONTIERS IN ONCOLOGY (2019)
Novel therapy in Acute myeloid leukemia (AML): moving toward targeted approaches
Eric S. Winer et al.
THERAPEUTIC ADVANCES IN HEMATOLOGY (2019)
The Ontogeny of a Neutrophil: Mechanisms of Granulopoiesis and Homeostasis
Shelley M. Lawrence et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2018)
A Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization
Miguel F. Sanmamed et al.
CELL (2018)
Clinical Efficacy of a Novel Therapeutic Principle, Anakoinosis
Daniel Heudobler et al.
FRONTIERS IN PHARMACOLOGY (2018)
Biomodulatory Treatment With Azacitidine, All-trans Retinoic Acid and Pioglitazone Induces Differentiation of Primary AML Blasts Into Neutrophil Like Cells Capable of ROS Production and Phagocytosis
Sebastian Klobuch et al.
FRONTIERS IN PHARMACOLOGY (2018)
Cutaneous Leukemic Infiltrates Successfully Treated With Biomodulatory Therapy in a Rare Case of Therapy-Related High Risk MDS/AML
Daniel Heudobler et al.
FRONTIERS IN PHARMACOLOGY (2018)
An Organoruthenium Anticancer Agent Shows Unexpected Target Selectivity For Plectin
Samuel M. Meier et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2017)
S100A9 induces differentiation of acute myeloid leukemia cells through TLR4
Malika Laouedj et al.
BLOOD (2017)
Response Profiling Using Shotgun Proteomics Enables Global Metallodrug Mechanisms of Action To Be Established
Dominique Kreutz et al.
CHEMISTRY-A EUROPEAN JOURNAL (2017)
Anticancer Gold(III) Porphyrins Target Mitochondrial Chaperone Hsp60
Di Hu et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
Arsenic trioxide augments all-trans retinoic acid-induced differentiation of HL-60 cells
Daigo Sumi et al.
LIFE SCIENCES (2016)
Mitonuclear communication in homeostasis and stress
Pedro M. Quiros et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2016)
Acute myeloid leukemia: a comprehensive review and 2016 update
I. De Kouchkovsky et al.
BLOOD CANCER JOURNAL (2016)
Retinoic acid and arsenic trioxide trigger degradation of mutated NPM1, resulting in apoptosis of AML cells
Hiba El Hajj et al.
BLOOD (2015)
Transcriptional Heterogeneity and Lineage Commitment in Myeloid Progenitors
Franziska Paul et al.
CELL (2015)
Induction of autophagy is a key component of all-trans-retinoic acid-induced differentiation in leukemia cells and a potential target for pharmacologic modulation
Nina Orfali et al.
EXPERIMENTAL HEMATOLOGY (2015)
Induced myelomonocytic differentiation in leukemia cells is accompanied by noncanonical transcription factor expression
Holly A. Jensen et al.
FEBS OPEN BIO (2015)
Biomodulatory therapy induces complete molecular remission in chemorefractory acute myeloid leukemia
Simone Thomas et al.
HAEMATOLOGICA (2015)
Retinoic acid synergizes ATO-mediated cytotoxicity by precluding Nrf2 activity in AML cells
M. Valenzuela et al.
BRITISH JOURNAL OF CANCER (2014)
What's your age again? Determination of human neutrophil half-lives revisited
Tamar Tak et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2013)
Novel metal(II) arene 2-pyridinecarbothioamides: a rationale to orally active organometallic anticancer agents
Samuel M. Meier et al.
CHEMICAL SCIENCE (2013)
Quantitative mass spectrometry in proteomics: critical review update from 2007 to the present
Marcus Bantscheff et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2012)
From an old remedy to a magic bullet: molecular mechanisms underlying the therapeutic effects of arsenic in fighting leukemia
Sai-Juan Chen et al.
BLOOD (2011)
Inflammasome activation and IL-1β and IL-18 processing during infection
Frank L. van de Veerdonk et al.
TRENDS IN IMMUNOLOGY (2011)
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
Hartmut Doehner et al.
BLOOD (2010)
NDRG1/2 expression is inhibited in primary acute myeloid leukemia
Mario P. Tschan et al.
LEUKEMIA RESEARCH (2010)
The resurgence of platinum-based cancer chemotherapy
Lloyd Kelland
NATURE REVIEWS CANCER (2007)
Arsenic trioxide and proteasome inhibitor bortezomib synergistically induce apoptosis in leukemic cells:: the role of protein kinase Cδ
H. Yan et al.
LEUKEMIA (2007)
Systems analysis of transcriptome and proteome in retinoic acid/arsenic trioxide-induced cell differentiation/apoptosis of promyelocytic leukemia
PZ Zheng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Proteasome activation by poly-ADP-ribose-polymerase in human myelomonocytic cells after oxidative stress
O Ullrich et al.
FREE RADICAL BIOLOGY AND MEDICINE (2000)